Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

Abstract Background Prostate cancer (PrCa) genomic heterogeneity causes resistance to therapies such as androgen deprivation. Such heterogeneity can be deciphered in the context of evolutionary principles, but current clinical trials do not include evolution as an essential feature. Whether or not a...

Full description

Bibliographic Details
Published in:	Genome Medicine
Main Authors:	Anssi Nurminen, Serafiina Jaatinen, Sinja Taavitsainen, Gunilla Högnäs, Tom Lesluyes, Naser Ansari-Pour, Teemu Tolonen, Kerstin Haase, Antti Koskenalho, Matti Kankainen, Juho Jasu, Hanna Rauhala, Jenni Kesäniemi, Tiia Nikupaavola, Paula Kujala, Irina Rinta-Kiikka, Jarno Riikonen, Antti Kaipia, Teemu Murtola, Teuvo L. Tammela, Tapio Visakorpi, Matti Nykter, David C. Wedge, Peter Van Loo, G. Steven Bova
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Subjects:	Prostate cancer Cancer evolution Cancer timing Cancer anatomic origins Spatiogenomic evolutionary tracing Prostate cancer metastasis
Online Access:	https://doi.org/10.1186/s13073-023-01242-y

Similar Items

Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine
by: Juho Jasu, et al.
Published: (2021-08-01)

Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation
by: Heikki Seikkula, et al.
Published: (2020-03-01)

Testosterone levels at diagnosis: A key predictor of overall survival among patients with prostate cancer
by: Ilkka Jussila, et al.
Published: (2025-02-01)

Fanconi anemia pathway regulation by FANCI in prostate cancer
by: Heidi Kaljunen, et al.
Published: (2023-10-01)

Previous inguinal hernia surgery does not limit the likelihood of choosing prostatectomy as primary prostate cancer therapy
by: Mikko Ahtinen, et al.
Published: (2024-04-01)

Differences in Gut Microbiota Profiles and Microbiota Steroid Hormone Biosynthesis in Men with and Without Prostate Cancer
by: Sofia Kalinen, et al.
Published: (2024-04-01)

The present and future of prostate cancer. The importance of physical activity - a comprehensive review of the literature
by: Tomasz Kucharski, et al.
Published: (2024-07-01)

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
by: Rodolfo Montironi, et al.
Published: (2020-04-01)

Prostate cancer - risk factors and prevention strategies
by: Jakub Rybak, et al.
Published: (2023-10-01)

Cost Analysis of Screening for, Diagnosing, and Staging Prostate Cancer Based on a Systematic Review of Published Studies
by: Donatus U. Ekwueme, PhD, et al.
Published: (2007-10-01)

Long-term outcomes of nonpalpable prostate cancer (T1c) patients treated with radical prostatectomy
by: Yoshiyasu Amiya, et al.
Published: (2015-03-01)

Effect of Glison index on survival of patients with localized prostate cancer in Samara region
by: R. D. Andreeva, et al.
Published: (2022-05-01)

Clinical Issues for Prostate-Specific Antigen Screening: A Narrative Review
by: Marco Randazzo, et al.
Published: (2018-12-01)

Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies
by: Isis Wolf, et al.
Published: (2022-07-01)

The Impact of Atorvastatin on Intraprostatic Biomarkers – Prognostic Value of 3LS-score – Follow-up of ESTO1-Trial
by: Eemil Lehtonen, et al.
Published: (2025-03-01)

Atorvastatin induces adrenal androgen downshift in men with prostate cancer: A post Hoc analysis of a pilot adaptive Randomised clinical trial
by: Paavo V.H. Raittinen, et al.
Published: (2021-06-01)

Prostate Cancer: Advances in Genetic Testing and Clinical Implications
by: Ahmad S. Abdelrazek, et al.
Published: (2023-03-01)

Analysis of innovative clinical developments in the field of therapy for metastatic prostate cancer: bright results of the ASCO Congress-2022
by: D. A. Andreev, et al.
Published: (2022-06-01)

The Current Therapeutic Landscape for Metastatic Prostate Cancer
by: Anastasia Bernal, et al.
Published: (2024-03-01)

Prostatectomía radical citorreductora comparado a no realizar tratamiento local en pacientes con cáncer de próstata metastásico
by: Catalina González-Browne, et al.
Published: (2023-05-01)

Ureteral metastasis from locally invasive, castrate-resistant prostate cancer: a case report
by: Zachary C. Janatpour, et al.
Published: (2021-11-01)

Lung malignancy in prostate cancer: A report of both metastatic and primary lung lesions
by: Lael Reinstatler, et al.
Published: (2018-01-01)

A case report of a prostate cancer metastasis in the pancreas exhibiting vascular encasement
by: Lauren Phung, BS, et al.
Published: (2024-03-01)

Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study
by: Jeffrey J. Tosoian, et al.
Published: (2021-07-01)

Interobserver Variability of Gleason Score and Completeness of Histopathology Report in Prostatic Adenocarcinoma in Prostate Needle Biopsy Specimens Among General Pathologists in a Multi-institutional Setting.
by: Anne Lizbeth Valdez, et al.
Published: (2018-09-01)

Prostate cryoablation: A mini review
by: Zheng Xia, et al.
Published: (2023-12-01)

Role of serum cathelicidin in diagnosis of patient with prostatitis and prostate carcinoma
by: Necla Benlier, et al.
Published: (2022-12-01)

Prostate diseases in Lagos, Nigeria: A histologic study with tPSA correlation
by: C C Anunobi, et al.
Published: (2011-01-01)

The Capio Prostate Cancer Center Model for Prostate Cancer Diagnostics—Real-world Evidence from 2018 to 2022
by: Thorgerdur Palsdottir, et al.
Published: (2024-03-01)

Prostate cancer was detected after radical resection of urinary bladder cancer
by: Yalin Yang, et al.
Published: (2024-04-01)

Seminal vesicle sparing robotic radical prostatectomy – no different interpretation of postoperative PSA follow-up required?
by: Patrick Betschart, et al.
Published: (2019-01-01)

Association Between Prostate Cancer Detection Rate and Year of Prostate Biopsy
by: Young Jun Uhm, et al.
Published: (2025-02-01)

Cross-cultural adaptation and psychometric validation of the Finnish version of the Expanded Prostate Cancer Index Composite-26 for patients with localised prostate cancer
by: Otto Ettala, et al.
Published: (2025-08-01)

Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
by: Lina Merkens, et al.
Published: (2022-02-01)

Single-Center Comparative Evaluation of Freehand Transperineal and Transrectal Prostate Biopsy Techniques Performed Under Local Anesthesia
by: Laurian Ștefan Maxim, et al.
Published: (2025-07-01)

Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study
by: Jyothirmayi Velaga, et al.
Published: (2023-12-01)

Current Role of Magnetic Resonance Imaging in the Screening, Diagnosis, and Treatment of Prostate Cancer
by: Sven Nikles, et al.
Published: (2022-01-01)

Renal cancer combined with prostate cancer with ureteral metastasis: A case report
by: Bo Chen, et al.
Published: (2024-09-01)

Advanced prostate cancer diagnosed by bone metastasis biopsy immediately after initial negative prostate biopsy: a case report and literature review
by: Mingwen Liu, et al.
Published: (2024-05-01)

Cytotoxic effect of Trigonella coerulescens subsp. ayvalikensis Erdoğan, Selvi & Tümen in prostate and colon cancer cell lines
by: Selami Selvi, et al.
Published: (2024-11-01)